BMS-955176 Bioavailability from new Formulations (QBR116570)

• Research type

  Research Study

• Full title

  Assessment of BMS-955176 Bioavailability from a Micronized Crystalline Tablet Relative to a Spray-Dried Dispersion Suspension and Assessment of Additional Experimental Formulations Relative to the Micronized Crystalline Tablet in Healthy Subjects

• IRAS ID

  147353

• Contact name

  Philip Evans

• Contact email

  phil.evans@quotientclinical.com

• Sponsor organisation

  Bristol Myers Squibb International Corporation

• Eudract number

  2013-004896-10

• ISRCTN Number

  to be registered

• Clinicaltrials.gov Identifier

  NCT02095886

• REC name

  Wales REC 1

• REC reference

  14/WA/0026

• Date of REC Opinion

  19 Feb 2014

• REC opinion

  Further Information Favourable Opinion